ERGOMED
Founded in 1997, Ergomed is a full-service partner for Phase I-IV clinical development and trial management, with expertise in oncology and rare disease drugs. Our portfolio includes novel therapies, early phase development, immunotherapy, and adaptive trial designs. We adopt a patient-centric approach and have access to global patients in crucial geographic regions. Our proven delivery record, expertise, and true partnership allow sponsors to trust us to manage their oncology trials, including industry-leading PV solutions through PrimeVigilance.